AETHLON MEDICAL INC

Nasdaq:AEMD

Surgical & Medical Instruments & Apparatus·SAN DIEGO, CA

Summary Financials

Revenue

$574,245

+95.2% YoY

FY 2024

Adj. EBITDA

-$12.3M

-2138.0% margin

FY 2025

Net Income

-$12.2M

-2126.0% margin

FY 2025

EPS (Diluted)

-$38.87

FY 2025

Stock Price

$1.74

+0.0%

2026-03-09

52W Range

$1.68 – $36.75

P/E Ratio

-0.0x

Market Cap

$2.3M

Cash

$5.4M

FY 2025

Total Debt

$390,000

FY 2015

Net Cash

$5.1M

FY 2015

Enterprise Value

-$2.8M

Debt / EBITDA

0.4x

FY 2024

EV / EBITDA

0.2x

Employees

—

Revenue

$574,245

+95.2% YoY

FY 2024

Adj. EBITDA

-$12.3M

-2138.0% margin

FY 2025

Net Income

-$12.2M

-2126.0% margin

FY 2025

EPS (Diluted)

-$38.87

FY 2025

Stock Price

$1.74

+0.0%

2026-03-09

52W Range

$1.68 – $36.75

P/E Ratio

-0.0x

Market Cap

$2.3M

Cash

$5.4M

FY 2025

Total Debt

$390,000

FY 2015

Net Cash

$5.1M

FY 2015

Enterprise Value

-$2.8M

Debt / EBITDA

0.4x

FY 2024

EV / EBITDA

0.2x

Employees

—